Primary open-angle glaucoma (POAG) is a common, potentially blinding ocular condition. It is characterised by a raised intraocular pressure (IOP), with secondary damage to the optic nerve, and consequent loss of visual field. Treatment is directed towards lowering the IOP, and the first line of treatment consists in topical medication with an ocular hypotensive, for example timolol, often in conjunction with oral therapy such as acetazolamide. However, the response may be insufficient by pharmacological methods alone.
Laser trabeculoplasty (LTP) for the treatment of uncontrolled glaucoma was first described by Wise and Witter in 1979.' It has since become an established treatment, with several studies demonstrating its effectiveness.23 It is a technique whereby a number of laser burns are applied to the trabecular meshwork of the angle of the anterior chamber of the eye. LTP is usually performed with an argon laser, which emits blue-green radiation (wavelength 488-514-5 nm), though a similar ocular hypotensive action has been demonstrated with krypton red (647 nm)4 and neodymium-YAG (1064 nm) laser radiation. 5 In the present study a portable semiconductor diode laser, emitting at 810 nm, was used to examine the clinical effects of near-infrared irradiation of the trabecular meshwork. The purpose of this study was to evaluate the ocular hypotensive action of diode laser trabeculoplasty (DLT) in the treatment of patients with primary open-angle glaucoma. In this preliminary investigation randomised comparison with argon laser trabeculoplasty was not performed.
Materials and methods

INSTRUMENTATION
A diode laser was used in the study which could be attached to a standard Haag-Streit slit-lamp. The The intraocular pressures were measured two to three hours after therapy. A transient rise in pressure would be treated with a drop of timolol 0-5%. The patients were asked to continue with their current glaucoma medication.
POST-TREATMENT REVIEW
The patients were reviewed at two weeks, six weeks, and 12 weeks after treatment and at twoto three-month intervals thereafter. At each visit the ocular examination included measurement of visual acuity, anterior segment examination, intraocular pressures and funduscopy, including examination of the optic discs.
If a satisfactory ocular hypotensive effect was achieved, with the IOP less than 22 mmHG, a reduction of the patient's ocular medication was considered.
An unsatisfactory response to treatment was considered to be failure of the intraocular pressure to fall to less than 22 mmHg at six weeks after laser therapy. In this case laser trabeculoplasty was repeated to the other 1800 ofthe angle. Continued failure to control the IOP would lead to consideration of operative intervention. This generally occurred at power settings of between 800 and 1200 mW. In eyes with poor trabecular pigmentation this response was more difficult to identify. Formation of gas bubbles at the site of laser irradiation was not observed.
CLINICAL RESULTS
The mean period of review was eight months (range 6-12 months). Seven patients had bilateral DLT, and six had treatment to one eye only. Sixteen eyes had one treatment with the diode laser, and four eyes had two treatments. Intraocular pressures. The mean pretreatment intraocular pressure was 28-3 mmHg (range 22-36). The mean IOP two weeks after laser trabeculoplasty was 18-1 mmHg (range [14] [15] [16] [17] [18] [19] [20] [21] [22] . It was noted that in three of the six patients who had treatment to one eye the intraocular pressure was lower in the untreated eye than before treatment (by 3, 4, and 8 mmHg). In the remaining untreated eyes there was no change in intraocular pressure. went.
The precise mechanism for the pressure lowering effect of LTP is unknown. One theory suggests that photocoagulation results in contraction of trabecular fibres, which opens Schlemm's canal by drawing the attached trabecular fibres inward.7 Another proposes that laser irradiation causes degenerative decay of the trabecular fibres, with a secondary widening of the intertrabecular spaces.8 Whatever the mechanism of action, it is agreed that the beneficial effect of LTP is to cause a decrease in resistance to aqueous outflow9 and an improvement in aqueous outflow facility.2' 1 There is also evidence to suggest a more complex biological response to irradiation, with an increase in trabecular cell division, which may also influence the outflow facility."I The observation of a comparable hypotensive effect of diode laser trabeculoplasty with treatment by lasers of other wavelengths implies a similar mode of action. The deeper penetration of infrared into the relatively poorly pigmented trabecular meshwork than with argon blue has been observed in a recent histological study.'2
Possibly this results in a more marked effect on intraocular pressure, either through a greater degree of opening of the trabecular spaces or in promoting more widespread division of those trabecular cells which may play an active role of aqueous outflow.'3 The validity of this speculation awaits the results of further investigations.
The desired visible end point of a trabecular exposure was a mild blanching of the pigmented portion of the trabecular meshwork. This was based on the responses noted during histopathological studies.'2 Gas bubble formation was not a feature of any reaction. This may be related to the characteristics of the tissue response to infrared irradiation, in that the dissipation of energy over a greater path length results in a lower posibility of explosive tissue disruption. Alternatively, it may be due to the powers selected being below the threshold required for formation of gas bubbles.
It is a feature of the treatment protocol of several series that gas bubble formation should be caused as part of the end point.2'10 The rationale for this has never been satisfactorily explained. Indeed there is some evidence that it has an adverse effect on the eye. It is recognised that LTP is often accompanied by a transient rise in intraocular pressure."' This phenomenon may put any eye which is already compromised at risk of further loss of visual field. I ' The present study with the diode laser found no acute rise in IOP following therapy in any of the eyes treated, even in those eyes with deeply pigmented trabeculae -for example, in black patients. As the desired reaction was to produce a mild blanching of the trabecular meshwork with each burn and bubble formation was not a feature of the exposures, it seems clear that the lesions were only just above threshold in character. There would then be a reduced likelihood ofexcessive damage to trabecular fibres and of obstruction to aqueous outflow. The mildness of anterior segment inflammation following therapy may also be related to the powers employed in treatment.
Without a detailed knowledge of the mechanisms underlying laser trabeculoplasty it is difficult to optimise the procedure; but clearly the beneficial effects of laser trabeculoplasty do not depend on excessive irradiation of the trabeclar meshwork. One study treated patients with argon LTP, with one group being treated with 100 burns at 1 W, and the other group being treated with 65 burns at 850 mW. No significant difference was found in the rate of success for each group.'6 Tissue culture experiments have been performed in which cat trabecular meshwork was irradiated with an argon laser at power settings of 300 mW and at 1000 mW, with no differences being found in the rate of induced cell division between the two groups. 1 '
The powers used in the present study were of the order of 1 watt and therefore similar to those used with argon LTP. However, the lower absorption of infrared (810 nm) within melanin compared with that of argon blue-green radiation (488-514-5 nm)s implies less energy deposition with diode irradiation at comparable power levels. This should lead to less tissue damage with diode exposures, but clearly a similar clinical response was observed.
It was interesting that in several patients a reduction in pressure was noted in the contralateral, untreated eye. This was described by Fink et al, '9 in their series of 34 eyes. They found an average decrease of 4-2 mmHg in the untreated eyes compared with 9-9 mmHg in the treated eyes. This raises the possibility of the influence of neurogenic factors or systemically disseminated chemical mediators.
The limited review period of the present series does not allow any conclusions to be drawn regarding the longer term efficacy of diode laser trabeculoplasty. Previous studies of argon LTP report a maximum pressure lowering effect occurring between two months20 and 6-9 months after treatment. ' 
